Journal of Cancer Immunology & Therapy

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Short Communication - Journal of Cancer Immunology & Therapy (2023) Volume 6, Issue 3

The role of natural killer cells in cancer immune surveillance.

Faisal Noreen*

Department of Bioinformatics, Hazara University Mansehra, Pakistan

*Corresponding Author:
Faisal Noreen
Department of Bioinformatics
Hazara University Mansehra
Pakistan
E-mail:noreen_f56@gmail.com

Received:15-May-2023,Manuscript No. AAJCIT-23-102141; Editor assigned: 18-May-2023, PreQC No. AAJCIT-23-102141(PQ); Reviewed:01-Jun-2023, QC No. AAJCIT-23-102141; Revised:05-Jun-2023, Manuscript No. AAJCIT-23-102141(R); Published:12-Jun-2023, DOI: 10.35841/aajcit- 6.3.146

Citation: Noreen F. The role of natural killer cells in cancer immune surveillance. J Cancer Immunol Ther. 2023;6(3):146

Visit for more related articles at Journal of Cancer Immunology & Therapy

Introduction

Natural killer (NK) cells are a vital component of the immune system with the unique ability to recognize and eliminate malignant cells. In cancer immune surveillance, NK cells play a critical role in early detection and eradication of transformed cells, thus preventing tumor progression. This article provides a brief overview of the mechanisms by which NK cells contribute to cancer immune surveillance and highlights their potential in cancer immunotherapy. Understanding the intricate interactions between NK cells and tumor cells can pave the way for developing novel therapeutic strategies to harness the full potential of these innate immune cells. Cancer immune surveillance is a complex process that involves the recognition and elimination of transformed cells by the immune system. Among the various immune cells involved, natural killer (NK) cells have emerged as key players in this surveillance mechanism. This section provides a concise introduction to NK cells and their unique characteristics [1].

NK cell biology

This section delves into the biology of NK cells, describing their origin, development, and maturation in different tissues. The phenotypic markers that distinguish NK cells from other immune cells are also discussed, along with their diverse functions in immune responses.

NK cell recognition of tumor cells: NK cells employ an array of receptors to recognize and distinguish healthy cells from those that are stressed, infected, or transformed. The activation and inhibitory receptors on NK cells interact with ligands on target cells, determining the outcome of NK cell-mediated responses. This section elaborates on the mechanisms underlying NK cell recognition of tumor cells.

NK cell-mediated cytotoxicity: Once activated, NK cells exert their cytotoxic effects through multiple mechanisms. This section explores the cytotoxic pathways employed by NK cells, including the release of cytolytic granules containing perforin and granzymes, as well as the engagement of death receptors on target cells [2].

Regulation of nk cell activity: The activity of NK cells is tightly regulated to prevent unwarranted immune responses. The interplay between activating and inhibitory receptors on NK cells, along with the influence of cytokines and immune checkpoints, governs NK cell activation and function. This section provides insights into the regulatory mechanisms that modulate NK cell activity in the context of cancer immune surveillance.

Interactions between NK Cells and tumor microenvironment

The Tumor Microenvironment (TME) is a complex milieu that can influence NK cell function and survival. Various components of the TME, such as tumor cells, immune cells, and soluble factors, can either promote or hinder NK cell-mediated anti-tumor responses. This section elucidates the reciprocal interactions between NK cells and the TME [3].

Impairment of NK cell function in cancer

In certain cases, tumor cells can evade NK cell-mediated immune surveillance through various strategies. This section highlights the mechanisms employed by tumors to impair NK cell function, including the downregulation of ligands for activating receptors and the secretion of immunosuppressive factors

Exploiting NK cells in cancer immunotherapy

Given their potent anti-tumor capabilities, NK cells hold immense potential for cancer immunotherapy. This section discusses the current approaches being explored to harness the power of NK cells in the treatment of cancer, including adoptive cell therapy, cytokine-based therapies, and combination strategies [4].

Future perspectives and challenges

Although significant progress has been made in understanding the role of NK cells in cancer immune surveillance, several challenges remain. This section outlines future directions for research and highlights the need for innovative strategies to enhance NK cell-mediated anti-tumor responses [5].

Conclusion

NK cells play a crucial role in cancer immune surveillance through their ability to recognize and eliminate transformed cells. Understanding the intricate mechanisms underlying NK cell interactions with tumor cells and the TME is essential for developing effective cancer immunotherapies. Harnessing the potential of NK cells holds promise for improving patient outcomes and advancing the field of cancer immunology.

References

  1. Waldhauer I, Steinle ANK cells and cancer immunosurveillanceJ . Oncogene. 2008;27(45):5932-43.

    2. Indexed at, Google Scholar, Cross Ref

  2. Pende D, Cantoni C, Rivera P, et al.Role of NKG2D in tumor cell lysis mediated by human NK cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin.Eur J Immunol. 2001;31(4):1076-86.

    3. Indexed at, Google Scholar, Cross Ref

  3. Terabe M, Berzofsky JA.The role of NKT cells in tumor immunity. Adv Cancer Res. 2008;101:277-348.

    4. Indexed at, Google Scholar, Cross Ref

  4. Cassidy SA, Cheent KS, Khakoo SI, et al.Effects of Peptide on NK cell-mediated MHC I recognition. Front Immunol. 2014;5:133.

    5. Indexed at, Google Scholar, Cross Ref

  5. Iannello A, Debbeche O, Samarani S, et al.. Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS. J Leukoc Biol. 2008;84(1):1-26.

    6. Indexed at, Google Scholar, Cross Ref

Get the App